Suppr超能文献

肿瘤大小对pT2期肾细胞癌的预后影响:一项国际多中心研究经验

Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience.

作者信息

Klatte Tobias, Patard Jean-Jacques, Goel Rakhee H, Kleid Mark D, Guille Francois, Lobel Bernard, Abbou Clement-Claude, De La Taille Alexandre, Tostain Jacques, Cindolo Luca, Altieri Vincenzo, Ficarra Vincenzo, Artibani Walter, Prayer-Galetti Tommaso, Allhoff Ernst Peter, Schips Luigi, Zigeuner Richard, Figlin Robert A, Kabbinavar Fairooz F, Pantuck Allan J, Belldegrun Arie S, Lam John S

机构信息

Department of Urology, University of California, Los Angeles, Los Angeles, California 90095-1738, USA, and Centre Hospitalier Universitaire Pontchaillou, Rennes, France.

出版信息

J Urol. 2007 Jul;178(1):35-40; discussion 40. doi: 10.1016/j.juro.2007.03.046. Epub 2007 May 22.

Abstract

PURPOSE

The current tumor classification for renal cell carcinoma classifies pT2 tumors as larger than 7 cm in greatest dimension and limited to the kidney. We examined the current pT2 tumor classification of renal cell carcinoma and determined whether a tumor size cutoff exists that would improve prognostic accuracy.

MATERIALS AND METHODS

We studied 706 patients with pT2 renal cell carcinoma treated with surgical extirpation at 9 international academic centers. Data collected from each patient included age at diagnosis, gender, 2002 TNM (tumor, node, metastasis) stage, tumor size, nuclear grade, performance status, histological subtype and disease specific survival. Disease specific survival was evaluated with univariate and multivariate analysis.

RESULTS

Median followup was 52 months. Univariate Cox regression analysis showed a significant association of tumor size with disease specific survival (HR 1.11, p<0.001). An ideal tumor size cutoff of 11 cm was identified, which led to the stratification of 2 groups with respect to disease specific survival (p<0.0001) with 5 and 10-year survival rates of 73% and 65% for pT2 11 cm or less, and 57% and 49% for pT2 larger than 11 cm, respectively. The incidence of metastases was significantly greater in the larger than 11 cm group, while Eastern Cooperative Oncology Group performance status, Fuhrman grade and histological subtype were similar. Multivariate Cox regression analysis retained tumor size as an independent prognostic factor and as the strongest prognostic factor for patients with pT2N0M0 disease.

CONCLUSIONS

Our data suggest that the current pT2 classification can be improved by subclassification into pT2a and pT2b based on a tumor size cutoff of 11 cm. Patients in the proposed pT2bN0M0 group are at higher risk for death from renal cell carcinoma and should be considered for adjuvant therapies. External validation is warranted before suggesting change to the TNM classification.

摘要

目的

目前肾细胞癌的肿瘤分类将pT2肿瘤定义为最大径大于7 cm且局限于肾脏。我们研究了当前肾细胞癌的pT2肿瘤分类,并确定是否存在能提高预后准确性的肿瘤大小临界值。

材料与方法

我们研究了9个国际学术中心接受手术切除治疗的706例pT2肾细胞癌患者。从每位患者收集的数据包括诊断时的年龄、性别、2002年TNM(肿瘤、淋巴结、转移)分期、肿瘤大小、核分级、体能状态、组织学亚型和疾病特异性生存情况。采用单因素和多因素分析评估疾病特异性生存情况。

结果

中位随访时间为52个月。单因素Cox回归分析显示肿瘤大小与疾病特异性生存存在显著关联(风险比1.11,p<0.001)。确定了理想的肿瘤大小临界值为11 cm,这导致根据疾病特异性生存将患者分为两组(p<0.0001),pT2肿瘤直径11 cm及以下组的5年和10年生存率分别为73%和65%,pT2肿瘤直径大于11 cm组的5年和10年生存率分别为57%和49%。肿瘤直径大于11 cm组的转移发生率显著更高,而东部肿瘤协作组体能状态、福尔曼分级和组织学亚型相似。多因素Cox回归分析将肿瘤大小保留为独立预后因素,且是pT2N0M0疾病患者最强的预后因素。

结论

我们的数据表明,目前的pT2分类可通过基于11 cm的肿瘤大小临界值细分为pT2a和pT2b来改进。拟议的pT2bN0M0组患者死于肾细胞癌的风险更高,应考虑给予辅助治疗。在建议改变TNM分类之前,需要进行外部验证。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验